MicroRNA‐497/fibroblast growth factor‐23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end‐stage renal disease patients who underwent continuous ambulatory peritoneal dialysis

OBJECTIVE: This study aimed at exploring the correlation of microRNA (miR)‐497/fibroblast growth factor‐23 (FGF‐23) axis with major adverse cardiac and cerebral event (MACCE) occurrence in end‐stage renal disease (ESRD) patients who underwent continuous ambulatory peritoneal dialysis (CAPD). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dianjun, Zhou, Silian, Mao, Huihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307374/
https://www.ncbi.nlm.nih.gov/pubmed/32077150
http://dx.doi.org/10.1002/jcla.23220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307374/
https://www.ncbi.nlm.nih.gov/pubmed/32077150
http://dx.doi.org/10.1002/jcla.23220

Ejemplares similares